Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study

Published:2021-10 Issue: Volume:59 Page:79-86
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Mamguem Kamga Ariane,Billa Oumar,Ladoire Sylvain,Poillot Marie-Laure,Jolimoy Geneviève,Roignot Patrick,Coutant Charles,Desmoulins Isabelle,Maynadie Marc,Dabakuyo-Yonli Tienhan Sandrine

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference28 articles.

1. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Lancet,2011

2. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer;Hershman;Breast Canc Res Treat,2011

3. The “Arimidex”, Tamoxifen, Alone or in Combination (ATAC) Trial: a step forward in the treatment of early breast cancer;Howell;Rev Recent Clin Trials,2006

4. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer;N Engl J Med,2005

5. Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial;Derks;Lancet Oncol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP